Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

ARVINAS, INC.

ARVN · Nasdaq · CIK 0001655759 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

14 Form 4 transaction lines observed in the same window
8 sales · 6 option, withholding, award, gift or other lines

Last qualifying purchase2026-03-06 · Morrison Briggs · $268.0K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Saik AndrewChief Financial Officer
▼▼
Cacace Angela MChief Scientific Officer
▼▼
Teel RandyPresident and CEO
▼▼
Smaldone Alsup LaurieDirector
○
Norwalk Leslie VDirector
○
Morrison BriggsDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-03-06 · Morrison Briggs.

Recent Form 4 activity

1Purchases
23Sales
12Other Form 4 lines
32SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING8 sale line(s) · context only
OTHER6 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-18.0%
3M
-12.8%
6M
-33.5%
12M
-22.6%

Volatility & liquidity

Volatility
71.0%
Beta
—
Avg daily value
USD 5.8M

Valuation

Market cap
—
P/E
—

Fundamentals

Profit margin
-30.8%
ROE
-18.7%
Industry
Biotechnology

Market data

Price data up to: 2026-10-07 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Profit margin, ROE · Fiscal year ended: 2025-12-31 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
5,389,277
Previous report
4,986,181
Avg daily volume
819,217
Days to cover
6.6

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-03-06Morrison BriggsPurchase (P)Common Stock20,000USD 13.40USD 268,000SEC filing ↗
2025-09-22Morrison BriggsPurchase (P)Common Stock30,000USD 7.57USD 227,100SEC filing ↗
2020-12-18Ratcliffe LiamPurchase (P)Common Stock142,857USD 70.00USD 9,999,990SEC filing ↗
2020-11-09Kennedy Edward Moore Jr.Purchase (P)Common Stock8,333USD 23.99USD 199,909SEC filing ↗
2020-06-17SHANNON TIMOTHY MPurchase (P)Common Stock2,000USD 30.26USD 60,520SEC filing ↗
2020-06-02SHANNON TIMOTHY MPurchase (P)Common Stock3,000USD 32.30USD 96,900SEC filing ↗
2020-03-24Morrison BriggsPurchase (P)Common Stock2,500USD 38.18USD 95,450SEC filing ↗
2020-03-20SHANNON TIMOTHY MPurchase (P)Common Stock2,500USD 40.00USD 100,000SEC filing ↗

Form 4 evidence

36 transaction lines in the latest 365-day window; 313 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-24Smaldone Alsup LaurieAward / grant (A)Common Stock15,527USD 0.00USD 0SEC filing ↗
2026-06-24Norwalk Leslie VAward / grant (A)Common Stock15,527USD 0.00USD 0SEC filing ↗
2026-06-24Morrison BriggsAward / grant (A)Common Stock15,527USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-24Smaldone Alsup LaurieAward / grant (A)Common Stock15,527USD 0.00USD 0SEC filing ↗
2026-06-24Norwalk Leslie VAward / grant (A)Common Stock15,527USD 0.00USD 0SEC filing ↗
2026-06-24Morrison BriggsAward / grant (A)Common Stock15,527USD 0.00USD 0SEC filing ↗
2026-06-24Kennedy Edward Moore Jr.Award / grant (A)Common Stock15,527USD 0.00USD 0SEC filing ↗
2026-06-24Cunningham EverettAward / grant (A)Common Stock15,527USD 0.00USD 0SEC filing ↗
2026-06-24Bain LindaAward / grant (A)Common Stock15,527USD 0.00USD 0SEC filing ↗
2026-06-24Saik AndrewSale (S)Common Stock5,696USD 8.16USD 46,479SEC filing ↗
2026-06-17Cacace Angela MSale (S)Common Stock2,576USD 7.60USD 19,578SEC filing ↗
2026-05-21Teel RandySale (S)Common Stock2,209USD 9.04USD 19,969SEC filing ↗
2026-05-11Teel RandySale (S)Common Stock9,657USD 9.94USD 95,991SEC filing ↗
2026-05-11Saik AndrewSale (S)Common Stock11,139USD 9.94USD 110,722SEC filing ↗
2026-05-11Loomis David KSale (S)Common Stock1,919USD 9.94USD 19,075SEC filing ↗
2026-05-11Cacace Angela MSale (S)Common Stock9,657USD 9.94USD 95,991SEC filing ↗
2026-05-11Berkowitz NoahSale (S)Common Stock11,108USD 9.94USD 110,414SEC filing ↗
2026-03-18Berkowitz NoahSale (S)Common Stock6,435USD 11.10USD 71,428SEC filing ↗
2026-03-06Morrison BriggsPurchase (P)Common Stock20,000USD 13.40USD 268,000SEC filing ↗
2026-02-27Houston John GSale (S)Common Stock35,297USD 13.21USD 466,154SEC filing ↗
2026-02-26Teel RandyAward / grant (A)Common Stock147,179USD 0.00USD 0SEC filing ↗
2026-02-26Teel RandyAward / grant (A)Common Stock147,791USD 0.00USD 0SEC filing ↗
2026-02-26Saik AndrewAward / grant (A)Common Stock45,000USD 0.00USD 0SEC filing ↗
2026-02-26Loomis David KAward / grant (A)Common Stock12,420USD 0.00USD 0SEC filing ↗
2026-02-26Cacace Angela MAward / grant (A)Common Stock45,000USD 0.00USD 0SEC filing ↗
2026-02-26Berkowitz NoahAward / grant (A)Common Stock45,000USD 0.00USD 0SEC filing ↗
2026-02-23Teel RandySale (S)Common Stock4,786USD 12.16USD 58,198SEC filing ↗
2026-02-23Loomis David KSale (S)Common Stock1,108USD 12.16USD 13,473SEC filing ↗
2026-02-23Cacace Angela MSale (S)Common Stock3,609USD 12.16USD 43,885SEC filing ↗
2026-02-13Teel RandySale (S)Common Stock4,403USD 11.89USD 52,352SEC filing ↗
2026-02-13Saik AndrewSale (S)Common Stock5,134USD 11.89USD 61,043SEC filing ↗
2026-02-13Loomis David KSale (S)Common Stock1,016USD 11.89USD 12,080SEC filing ↗
2026-02-13Cacace Angela MSale (S)Common Stock4,592USD 11.89USD 54,599SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerARVN
CIK0001655759
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history313 transaction lines from 2020-01-28 to 2026-06-24
8 P purchase lines · 185 S sale lines · 120 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.